Melanoma In Situ — Trials

Melanoma In Situ — Trials · CancerIndex

Clinical trials

Registered studies

19 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Institute of Health Information and Statistics of the Czech Republic
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02723721	Prospective Study of Ingenol Mebutate for Non-invasive Lentigo Melanoma of the Face(PICAMEL)	completed	Phase 2	20	Centre Hospitalier Universitaire de NiceOTHER	1	Mar 24, 2026	clinicaltrials
NCT01088737	Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna	unknown	Phase 2 / Phase 3	60	Medical University of GrazOTHER	1	Aug 13, 2019